Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platforms.
Two novel side chains which had previously been found to enhance antagonist activity in the dihydrobenzoxathiin SERM series were applied to three existing platforms. The novel side chains did not improve the antagonist activity of the existing platforms.